Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia.

Zhang HY, Zheng CY, Yan H, Wang ZF, Tang LL, Gao X, Tang XC.

Chem Biol Interact. 2008 Sep 25;175(1-3):396-402. doi: 10.1016/j.cbi.2008.04.049. Epub 2008 May 13. Review.

PMID:
18565502
2.

Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.

Wang R, Yan H, Tang XC.

Acta Pharmacol Sin. 2006 Jan;27(1):1-26. Review.

3.

Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase.

Zhang HY, Yan H, Tang XC.

Cell Mol Neurobiol. 2008 Feb;28(2):173-83. Epub 2007 Jul 27. Review.

PMID:
17657601
4.

Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease.

Zhang HY, Tang XC.

Trends Pharmacol Sci. 2006 Dec;27(12):619-25. Epub 2006 Oct 23.

PMID:
17056129
5.
6.

In vitro production of huperzine A, a promising drug candidate for Alzheimer's disease.

Ma X, Gang DR.

Phytochemistry. 2008 Jul;69(10):2022-8. doi: 10.1016/j.phytochem.2008.04.017. Epub 2008 Jun 5.

PMID:
18538805
8.

Huperzine A from Huperzia species--an ethnopharmacolgical review.

Ma X, Tan C, Zhu D, Gang DR, Xiao P.

J Ethnopharmacol. 2007 Aug 15;113(1):15-34. Epub 2007 Jun 2. Review.

PMID:
17644292
9.

Bivalent ligands derived from Huperzine A as acetylcholinesterase inhibitors.

Haviv H, Wong DM, Silman I, Sussman JL.

Curr Top Med Chem. 2007;7(4):375-87. Review.

PMID:
17305579
10.

Huperzine A protects isolated rat brain mitochondria against beta-amyloid peptide.

Gao X, Zheng CY, Yang L, Tang XC, Zhang HY.

Free Radic Biol Med. 2009 Jun 1;46(11):1454-62. doi: 10.1016/j.freeradbiomed.2009.02.028. Epub 2009 Mar 9.

PMID:
19272446
11.

Role of huperzine a in the treatment of Alzheimer's disease.

Desilets AR, Gickas JJ, Dunican KC.

Ann Pharmacother. 2009 Mar;43(3):514-8. doi: 10.1345/aph.1L402. Epub 2009 Feb 24. Review.

PMID:
19240260
12.

Huperzine A (shuangyiping): a promising drug for Alzheimer's disease.

Tang XC.

Zhongguo Yao Li Xue Bao. 1996 Nov;17(6):481-4. Review.

PMID:
9863136
13.

Quantitative proteomic analysis reveals the neuroprotective effects of huperzine A for amyloid beta treated neuroblastoma N2a cells.

Tao Y, Fang L, Yang Y, Jiang H, Yang H, Zhang H, Zhou H.

Proteomics. 2013 Apr;13(8):1314-24. doi: 10.1002/pmic.201200437. Epub 2013 Apr 2.

PMID:
23424162
14.

Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A.

Yang L, Ye CY, Huang XT, Tang XC, Zhang HY.

J Alzheimers Dis. 2012;31(1):131-42. doi: 10.3233/JAD-2012-120274.

PMID:
22531425
15.

Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer's Disease?

Qian ZM, Ke Y.

Front Aging Neurosci. 2014 Aug 19;6:216. doi: 10.3389/fnagi.2014.00216. eCollection 2014. Review.

16.

Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.

Huang XT, Qian ZM, He X, Gong Q, Wu KC, Jiang LR, Lu LN, Zhu ZJ, Zhang HY, Yung WH, Ke Y.

Neurobiol Aging. 2014 May;35(5):1045-54. doi: 10.1016/j.neurobiolaging.2013.11.004. Epub 2013 Nov 13.

PMID:
24332448
17.

East meets West in the search for Alzheimer's therapeutics - novel dimeric inhibitors from tacrine and huperzine A.

Li WM, Kan KK, Carlier PR, Pang YP, Han YF.

Curr Alzheimer Res. 2007 Sep;4(4):386-96. Review.

PMID:
17908041
18.

Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice.

Wang Y, Tang XC, Zhang HY.

J Neurosci Res. 2012 Feb;90(2):508-17. doi: 10.1002/jnr.22775. Epub 2011 Oct 17.

PMID:
22002568
19.

Huperzine A--an interesting anticholinesterase compound from the Chinese herbal medicine.

Patocka J.

Acta Medica (Hradec Kralove). 1998;41(4):155-7. Review.

PMID:
9951045
20.

Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease.

Bai DL, Tang XC, He XC.

Curr Med Chem. 2000 Mar;7(3):355-74. Review.

PMID:
10637369

Supplemental Content

Support Center